Successful management of chronic refractory onycholysis by partial nail avulsion followed by topical tretinoin

Dear Editor,

Onycholysis is a common complaint in dermatologic clinics and consists of the separation of the nail plate from its distal bed. Due to its several etiologies (e.g. onychomycosis, neoplasia, trauma, contact dermatitis, psoriasis, lichen planus, and medications), it requires an intensive semiological practice and clinical suspicion prior to the definition of its therapeutic strategy.¹

Chronic onycholysis leads to keratinization of the nail bed and may cause a disappearing nail bed, defined as the shortening of the nail plate by more than 20% compared to an unaffected contralateral finger. In addition, subclinical bacterial proliferation may occur (e.g. Pseudomonas sp.), which makes chronic onycholysis even more challenging.²,³

This is the first report of successful treatment of chronic onycholysis by surgical avulsion of the onycholytic portion of the nail, followed by the application of topical tretinoin on the nail bed.

A 49-year-old female patient, without comorbidities or use of medications, presented with yellow-greenish fingernail discoloration of the right third finger, and shortening of the nail plate of the right first finger six years ago (Figure 1). The patient showed no improvement after successive previous oral (fluconazole) and topical (ketoconazole 2% cream and ciprofloxacin 0.3% eye drops) treatments. Mycological examination, culture, and nail clipping were all negative, leading to the hypothesis of chronic onycholysis and disappearing nail bed. Our therapeutic option was avulsion of the affected area (Figure 2) and daily treatment with tretinoin 0.025% gel on both nail beds, which resulted in complete improvement of the condition at a three-month follow-up (Figure 3).

Figure 1.

Onycholysis with yellowish-green discoloration suggesting underlying bacterial proliferation

Figure 2.

Partial nail avulsion of the onycholytic area with an intensely keratinized nail bed

Figure 3.

Result after three months of tretinoin 0.025% gel applied to the nail bed, with complete nail adhesion

Since onychomycosis represents the main cause of onycholysis and demands a long term specific treatment with potential toxicity, diagnostic investigation of onycholysis should be conducted with direct mycological exams, culture, and nail clipping.⁴ Dermoscopy and biopsy of nail plate and nail bed are additional elements for the diagnostic investigation.

Refractory onycholysis may also result from a long-standing onychomycosis, which, even if efficiently treated, may progress to bed keratinization and disappearing nail bed.

Partial avulsion of the onycholytic nail plate is a safe outpatient procedure under local anesthesia, which, by not manipulating the nail matrix or the lateral ligaments, does not pose a risk of posterior nail dystrophy. In addition, the clearing of the onycholytic portion of the nail favors cleaning, disinfection, and application of nail bed actives.

Retinoids have the potential to delay epithelial keratinization and increase the expression of intercellular adhesion molecules (e.g. desmosomes), which may promote the adhesion of the nail plate to the nail bed, as occurred in our case. Tazarotene is a third-generation retinoid approved for the treatment of acne and psoriasis. A double-blind, randomized, vehicle-controlled, parallel-group trial showed that the use of tazarotene 0.1% gel for 24 weeks was efficient in the treatment of onycholysis caused by psoriasis, in addition to a significant reduction in pitting in occluded nails. According to the authors, its effect on epithelial proliferation and nail bed keratinization rate would have led to the reversal of the onycholytic psoriasis phenotype, also acting on the nail matrix, reversing the pitting.⁵

The present case report aims to reinforce the need for the systematization of diagnostic investigation in patients with onycholysis and to demonstrate the effectiveness of the combination of surgical approach and keratinization modifiers to recover adhesion of the nail plate to the bed.

However, controlled clinical trials and other clinical and/or surgical approaches to the nail bed should be studied in order to establish effective strategies in the treatment of refractory onycholysis. Since there are only case reports published and the possibility of therapeutic failure, the need for alternative therapies is justified.

Financial support: None.

Conflict of interest: None.